EFFICACY AND TOXICITY OBSERVED IN MALIGNANT PLEURAL MESOTHELIOMA PATIENTS TREATED IN PHASE I TRIALS AT A SINGLE INSTITUTION

被引：0
|
作者：
Raphael, J. [1 ]
Hollebecque, A. [2 ]
Le Teuff, G. [3 ]
Massard, C. [2 ]
Bahleda, R. [2 ]
Margery, J. [4 ]
Besse, B. [1 ]
Soria, J. [1 ]
Planchard, D. [1 ]
机构：
[1] Inst Gustave Roussy, INSERM, Thorac Grp, U981, F-94805 Villejuif, France
[2] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
[3] Inst Gustave Roussy, Dept Stat & Epidemiol, Villejuif, France
[4] Percy Hosp, Dept Pulm, Paris, France
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：496 / 496
页数：1
相关论文
共 50 条
  • [21] Surgical treatment in the management of malignant pleural mesothelioma: A single institution's experience
    van Sandick, J. W.
    Kappers, I.
    Baas, P.
    Haas, R. L.
    Klomp, H. M.
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (06) : 1757 - 1764
  • [22] Clinical Outcome and Prognostic Factors for Advanced Malignant Mesothelioma (MM) Patients (pts) Treated on Phase I Trials
    Papadatos-Pastos, Dionysis
    Roda, Desamparados
    Luken, Maria Jose De Miguel
    Michalarea, Vasiliki
    Lima, Joao
    Diamantis, Nikolaos
    Capelan, Marta
    Jalil, Awais
    Bodla, Shankar
    Bhosle, Jaishree
    Molife, Rhoda
    O'Brien, Mary
    Banerji, Udai
    Popat, Sanjay
    Yap, Timothy A.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S504 - S505
  • [23] Results of phase I clinical trials of adenoviral interferon-β gene therapy for malignant mesothelioma and malignant pleural effusions
    Sterman, D. H.
    Recio, A.
    Haas, A.
    Vachani, A.
    Gillespie, C.
    Sun, J.
    Vonderheide, R.
    Kaiser, L. R.
    Albelda, S. M.
    LUNG CANCER, 2006, 54 : S50 - S51
  • [24] Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma
    Hughes, A
    Calvert, P
    Azzabi, A
    Plummer, R
    Johnson, R
    Rusthoven, J
    Griffin, M
    Fishwick, K
    Boddy, AV
    Verrill, M
    Calvert, H
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (16) : 3533 - 3544
  • [25] Diffuse malignant mesothelioma of the peritoneum - A clinicopathologic study of 35 patients treated locoregionally at a single institution
    Nonaka, D
    Kusamura, S
    Baratti, D
    Casali, P
    Cabras, AD
    Younan, R
    Rosai, J
    Deraco, M
    CANCER, 2005, 104 (10) : 2181 - 2188
  • [26] A retrospective analysis of malignant pleural mesothelioma patients treated either with chemotherapy or best supportive care between 1990 and 2005 - A single institution experience
    Metintas, Muzaffer
    Ak, Guntulu
    Erginel, Sinan
    Alatas, Fusun
    Yildirim, Huseyin
    Kurt, Emel
    Metintas, Selma
    LUNG CANCER, 2007, 55 (03) : 379 - 387
  • [27] Treatment for recurrence after extrapleural pneumonectomy for malignant pleural mesothelioma: A single institution experience
    Okamoto, Tatsuro
    Yano, Tokujiro
    Haro, Akira
    Yoshida, Tsukihisa
    Kohno, Mikihiro
    Maehara, Yoshihiko
    THORACIC CANCER, 2013, 4 (01) : 66 - 70
  • [28] A phase II study of gemcitabine in patients with malignant pleural mesothelioma
    van Meerbeeck, JP
    Bass, P
    Debruyne, C
    Groen, HJ
    Manegold, C
    Ardizzoni, A
    Gridelli, C
    van Marck, EA
    Lentz, M
    Giaccone, G
    CANCER, 1999, 85 (12) : 2577 - 2582
  • [29] Phase II study of vinorelbine in patients with malignant pleural mesothelioma
    Ost, E
    Illiger, HJ
    STRAHLENTHERAPIE UND ONKOLOGIE, 2001, 177 (08) : 440 - 441
  • [30] Phase II study of vinorelbine in patients with malignant pleural mesothelioma
    Steele, JPC
    Shamash, J
    Evans, MT
    Gower, NH
    Tischkowitz, MD
    Rudd, RM
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (23) : 3912 - 3917
12345